It is involved in the regulation of glucose and lipid metabolism, cardiovascular function, and amelioration of insulin resistance (IR) and has anti-inflammatory, anti-diabetic and anti-atherogenic properties; additionally, low circulating levels of adiponectin are associated with central obesity, insulin resistance, MS, and type 2 diabetes (T2DM)6, 7. This evidence concerns the gene ADIPOQ and myeloid sarcoma.